ReviewFrontiers in immunology2026
The peritoneal immune niche in peritoneal dialysis-induced membrane failure: macrophages, neutrophils and extracellular trap biology.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peritoneal dialysis (PD) is associated with progressive remodeling of the peritoneal membrane, with fibrosis, vasculopathy, and transport deterioration that culminate in ultrafiltration failure (UFF); a smaller subset of patients progresses to encapsulating peritoneal sclerosis (EPS). Myeloid-driven sterile inflammation is a central feature of this process, yet the evidence base differs sharply across the immune actors implicated. In this Perspective, we evaluate that evidence through a three-layer framework separating PD-direct data from non-PD peritoneal injury data and other-organ analogies. Macrophages are the best-established organizers of peritoneal niche remodeling. Neutrophils are well characterized in peritonitis but only gradually appear in chronic non-infectious functional disorders. Among extracellular traps, neutrophil extracellular traps (NETs) carry the strongest PD-specific signal: effluent proxies are linked to membrane transport phenotype and risk for technical failure. Macrophage extracellular traps (METs) rest on a single PD-specific mechanistic study and preliminary conference-level human data. We propose that chronic PD exposure conditions this niche and that second-hit inflammatory events (such as peritonitis) accelerate injury. If extracellular trap formation proceeds faster than nuclease- and macrophage-mediated clearance, trap-derived extracellular DNA may persist in the peritoneal cavity. We further hypothesize that, after uptake by bystander cells, cytosolic DNA sensing through cGAS-STING is engaged and may amplify membrane failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.